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Laboratoire d’Enzymologie et Biochimie Structurales, Centre Nationale de la Recherche Scientifique, Gif-sur-Yvette, FranceABSTRACT The aggregation of alpha-synuclein (a-syn) and huntingtin (htt) into fibrillar assemblies in nerve and glial cells is
a molecular hallmark of Parkinson’s and Huntington’s diseases. Within the aggregation process, prefibrillar and fibrillar oligo-
meric species form. Prefibrillar assemblies rather than fibrils are nowadays considered cytotoxic. However, recent reports
describing spreading of fibrillar assemblies from one cell to another, in cell cultures, animal models, and brains of grafted patients
suggest a critical role for fibrillar assemblies in pathogenesis. Here we compare the cytotoxic effect of defined and comparable
particle concentrations of on-assembly pathway oligomeric and fibrillar a-syn and Htt fragment corresponding to the first exon of
the protein (HttEx1). We show that homogeneous populations of a-syn and HttEx1 fibrils, rather than their precursor on-
assembly pathway oligomers, are highly toxic to cultured cells and induce apoptotic cell death. We document the reasons
that make fibrils toxic. We show that a-syn and HttEx1 fibrils bind and permeabilize lipid vesicles. We also show that fibrils
binding to the plasma membrane in cultured cells alter Ca2þ homeostasis. Overall, our data indicate that fibrillar a-syn and
HttEx1, rather than their precursor oligomers, are highly cytotoxic, the toxicity being associated to their ability to bind and
permeabilize the cell membranes.INTRODUCTIONAlzheimer’s, Parkinson’s (PD), and Huntington’s disease
(HD) are neurological human proteinopathies caused by
the accumulation at specific sites inside or outside the cells
of specific proteins’ high molecular mass, fibrillar, b-sheet-
rich, insoluble assemblies termed ‘‘amyloids’’.
In PD, the intracellular aggregates, which major constit-
uent is aggregated a-syn, are termed ‘‘Lewy bodies’’ and
‘‘Lewy neurites’’ (1,2). Alpha-synuclein (a-syn) is a 140-
residue presynaptic protein normally found in both soluble
and membrane-associated fractions of the brain (3) that is
believed to play an important role in the regulation of
synaptic vesicle release and trafficking, fatty acid binding,
and neuronal survival (4).
HD is a dominant heritable disorder linked to the pres-
ence of an abnormally long polyglutamine (polyQ) repeat
(37Q and over) in the N-terminal domain of huntingtin
(Htt), a large protein of ~3144 residues corresponding to
the expression of the 67 exons of the HTT gene. Htt is
expressed at its highest levels in the brain and plays an
essential role in early development, as well as in axonal traf-
ficking, regulation of gene transcription, and cell survival
(5). The proteolytic cleavage of disease associated full-
length Htt yields polyQ-containing N-terminal Htt frag-
ments corresponding to the exon 1 (HttEx1) (6) that have
a high propensity to aggregate and accumulate into cyto-
plasmic and nuclear inclusions in neurons (7,8).
Most neurological proteinopathies are believed to be due
to the formation of folding intermediates that self-associate
into nonnative oligomers that can elongate rapidly by incor-Submitted March 8, 2012, and accepted for publication April 30, 2012.
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0006-3495/12/06/2894/12 $2.00poration of monomers. Growth is unlimited, because as one
monomer is incorporated, a new binding site for yet another
monomer is created (9). In vitro, at physiological salt and
temperature, a-syn and HttEx1 assemble into fibrillar
aggregates that are structurally similar to those found in
the inclusions of disease-affected brains. Upon fibril forma-
tion, metastable prefibrillar oligomeric intermediates (that
are believed to represent precursors of mature fibrils) are
populated (10,11). Whether prefibrillar oligomeric and/or
fibrillar a-syn and HttEx1 assemblies are toxic to cells is
subject to intense debate and conflicting reports. Indeed,
although fibrillar a-syn, HttEx1 and other amyloidogenic
proteins have been shown to possess a cytotoxic potential
(12–15), the oligomers that form during the early stages of
assembly are considered most toxic, with the fibrils repre-
senting a storage or inert form (16–20). On-assembly
pathway oligomers and fibrils cytotoxicities are believed
to be the consequence of impairment of membrane integrity
and permeability (16,21,22) and the amplification of as-
semblies by recruitment of homolog endogenous protein
within the cytosol upon assemblies crossing the membrane
(23–26).
The recent findings reporting spreading of fibrillar assem-
blies from one cell to another, in cell cultures, animal
models, and brains of grafted patients, suggest a role for
fibrillar assemblies in pathogenesis (23,24,26,27). This,
together with the view that the abovementioned discrepancy
most probably originates from comparison of protein parti-
cles at different concentrations, prompted us to revisit the
respective cytotoxicity of a-syn and HttEx1 assemblies.
Indeed, at a given concentration of precursor protein the
concentrations of on-assembly pathway oligomers and
fibrils diverge by several orders of magnitude, given thatdoi: 10.1016/j.bpj.2012.04.050
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constituting molecules that differ very significantly.
Here, we compare for the first time (to our knowledge) the
cytotoxic effect of defined particle concentrations of on-
assembly pathway a-syn and HttEx1 oligomers and fibrils
of known size and molecular masses. We show that homo-
geneous populations of a-syn and HttEx1 fibrils, rather
than their precursors, are highly toxic to cultured cells and
induce apoptotic cell death.
We document the interaction of a-syn and HttEx1 fibrils
with synthetic phospholipid vesicles of different composi-
tion. We show that a-syn fibrils bind and permeabilize pref-
erentially vesicles made of anionic, rather than neutral,
phospholipids, whereas HttEx1 fibrils show no charge selec-
tivity. We assess the interaction of a-syn and HttEx1 fibrils
with the plasma membrane in cultured cells and show
fibrils-induced alterations in Ca2þ homeostasis.
Overall, our data indicate that fibrillar a-syn and HttEx1,
rather than their precursor oligomers, are highly cytotoxic,
the toxicity being associated to their ability to bind and
permeabilize the cell membranes.MATERIALS AND METHODS
Expression and purification of a-syn and
HttEx1Q41
The Escherichia coli strain BL21(DE3) (Stratagene, La Jolla, CA) was
transformed with the expression vector pRK172 encoding for a-syn.
Recombinant human wild-type a-syn was purified as described in Ghee
et al. (28). Recombinant HttEx1Q41 was purified from MBP-TEV-
HttEx1Q41 as described in the Supporting Material.Assembly of a-syn and HttEx1Q41 into fibrils
a-Syn and HttEx1Q41 assembly into fibrils was monitored as described in
the Supporting Material. To obtain fibril populations that are homogeneous
in size, fibrillar samples were sonicated for 20 min on ice in 2-ml Eppendorf
tubes in a VialTweeter powered by an ultrasonic processor UIS250v (250
watts, 2 4kHz; Hielscher Ultrasonic, Teltow, Germany) set at 75% ampli-
tude, 0.5 s pulses.
The analytical ultracentrifugation, quantitative electron microscopy, cell
viability assay, cell survival assay, caspase-3 activity measurements, prep-
aration of phospholipid unilamellar vesicles Htt and a-syn assemblies
membrane association assay, calcein release assay, a-syn and HttEx1Q41
labeling with extrinsic fluorophores, intracellular Ca2þ levels measure-
ments, epifluorescence microscopy imaging, and statistical analysis are
detailed in the Supporting Material.RESULTS
a-Syn assembly into fibrils, determination of the
particle concentration of oligomeric and fibrillar
a-syn and characterization of the a-syn toxic
species
a-Syn readily assembles in vitro, under physiological condi-
tions, into fibrils, as shown by the time-course measurement
of Thioflavin T binding (Fig. 1 a). Transmission electronmicroscopy (TEM) analysis after negative staining reveals
the presence of i), globular oligomers, with an average outer
diameter of ~20 nm (Fig. 1 b) within the lag phase preceding
assembly (e.g., 1–6 h after the onset of assembly), and ii),
mature fibrils, heterogeneous in length (Fig. 1 c), at steady
state (e.g., 40–50 h after the onset of assembly). The length
heterogeneity of the fibrils was reduced by sonication (Fig. 1
i, inset).
A comparison of the toxicity of monomeric, soluble
a-syn species that form during the lag phase, i.e., the on-
assembly pathway oligomeric (oligomeric a-syn) and
fibrillar a-syn based on the input concentration of the
soluble protein, does not reflect the specific toxicities.
This is due to the different forms of a-syn because the toxic-
ities of assemblies that are not monomeric, and made of very
different numbers of molecules, are compared. To estimate
the relative toxicities of monomeric, oligomeric, and
fibrillar a-syn one needs to determine the average number
of a-syn molecules in the two forms of assemblies. This
allows calculating the particle concentration of a-syn
assemblies for a given concentration of monomeric a-syn.
We used analytical ultracentrifugation and length distri-
bution measurements by quantitative TEM to estimate the
average number of monomeric a-syn within the oligomeric
and fibrillar assemblies.
The sedimentation velocities of monomeric, oligomeric,
and fibrillar a-syn were determined. For monomeric and
oligomeric a-syn, no rapidly sedimenting material was de-
tected while the rotor was accelerating to reach its operating
speed, ruling out the presence of large aggregates in freshly
thawed and oligomeric a-syn samples. The raw data were
modeled using the software Sedfit (National Institutes of
Health, Bethesda, MD) and the c(s) model. The best fits
yielded a single species with sedimentation coefficient
(s20,w) of 1.15 S for monomeric a-syn (not shown). The
sedimentation boundaries of oligomeric a-syn taken at
20-min intervals are presented in Fig. 1 d. Analysis of the
data (Fig. 1 e) reveals the presence of a predominant peak,
representing ~86% of the species, with sedimentation coef-
ficient (s20,w) of 1.15 S, consistent with the sedimentation
coefficient of monomeric a-syn (RH ¼ 2.98; f/f0 ¼ 1.85).
Nine additional peaks with higher sedimentation coeffi-
cients were observed (Fig. 1 e). They represent on-assembly
pathway a-syn oligomers that populate the lag phase
preceding fibrils formation. The sedimentation coefficient
(s20,w), the relative abundance of the different oligomeric
species, the average molecular mass, and the corresponding
oligomeric state of the species, calculated with the assump-
tion that a-syn oligomers are spherical particles, are given in
Table 1. Overall, the oligomeric species account for ~14%
of a-syn in solution. This number varies very little from
one measurement to another within a time-frame spanning
from 1 to 6 h after the onset of assembly.
For fibrillar a-syn, the sedimentation boundaries (Fig. 1 f)
were analyzed with the software Sedfit (National InstitutesBiophysical Journal 102(12) 2894–2905
FIGURE 1 Characterization of on-assembly
pathway oligomeric and fibrillar a-syn assemblies.
(a) Assembly kinetics of a-syn (200 mM)measured
by Thioflavin-T binding assay. Data are mean 5
SD. (n ¼ 4). (b and c) Negatively stained TEM
of on-assembly pathway a-syn oligomers (b) and
of mature a-syn fibrils (c). Scale bars, 200 nm.
(d) Sedimentation velocity data for oligomeric
a-syn (100-mM soluble protein concentration) at
50,000 rpm and 15C in assembly buffer. Shown
are sedimentation boundaries obtained at intervals
of 20 min. (e) Sedimentation coefficient contin-
uous c(s) distribution of oligomeric a-syn calcu-
lated from the sedimentation velocity data of
panel d and corrected to s20,w. (f) Sedimentation
velocity data for sonicated fibrillar a-syn (20-mM
soluble protein concentration) at 3000 rpm and
20C in assembly buffer. Shown are sedimentation
boundaries obtained at intervals of 5 min. (g) Sedi-
mentation coefficient g*(s) distribution of fibrillar
a-syn calculated from the sedimentation velocity
data of panel f and corrected to s20,w. (h) Sodium-
dodecyl-sulfate polyacrylamide-gel electropho-
resis analysis of the distribution of fibrillar a-syn
in the supernatant and pellet fractions upon centri-
fugation at 16,100  g for 15 min at 20C. (Total)
Noncentrifuged a-syn fibrils. (S) Supernatant. (P)
Pellet. (i) Length distribution of sonicated a-syn
fibrils obtained by measuring the length of ~2300
fibrils in at least 50 different quantitative nega-
tively stained TEM samples. (Inset) Representative
negatively stained TEM of sonicated a-syn fibrils.
Scale bar, 200 nm.
2896 Pieri et al.of Health), using the least-squares boundary modeling
ls-g*(s) that is most suited for heterogeneous mixtures of
large particles. This yielded a distribution of particles with
sedimentation coefficients ranging from 150 to 1500 S
(Fig. 1 g), centered on a species that has a sedimentation
coefficient of ~430 S, corresponding to particles that have
a molecular mass of ~125,000 kDa, e.g., made of ~8600
a-syn molecules (125,000 kDa/14.5 kDa).
These measurements allowed us to estimate an average
particle concentration of a-syn oligomers and of fibrillar
a-syn by knowing the initial concentration of the soluble
protein. The particle concentration of on-assembly pathway
a-syn oligomers was estimated using the equationBiophysical Journal 102(12) 2894–2905N ¼
X
½soluble a syn 

%Ni
ð100  niÞ

; (1)
where [soluble a-syn] is the initial concentration of the
soluble protein, %Ni is the relative abundance of each olig-
omeric species reported in Table 1, and ni is the average
number of monomers composing each oligomeric species.
Thus at the working concentration 20 mM, the overall
particle concentration of a-syn oligomers is ~0.5 mM. Simi-
larly, the particle concentration of fibrillar a-syn is 20
mM/~8600, i.e., ~0.002 mM, as 100% of a-syn is in a fibrillar
form at steady state. Indeed, 100% of the protein was found
TABLE 1 Sedimentation coefficients and relative abundances
of the different a-syn oligomeric species populating the lag
phase preceding assembly (100 mM protein monomer
concentration)
Sedimentation
coefficient s20,w (S)
Relative
abundance (%)
Estimated
MW (KDa)
Estimated
oligomeric state
1.15 85.62 14.5 Monomer
3.1 2.79 34.8 Dimer
4.8 3.01 69 Tetramer
~7.7–27 7.65 ~140–900 ~10–60 Monomers
Estimated molecular masses and the corresponding state of oligomerization
are also indicated.
The Cell Membrane and Fibrillar a-Syn and HttEx1 2897in the pellet fraction upon centrifugation at 16,100  g for
15 min at 20C of the fibrillar a-syn samples used
throughout this work (Fig. 1 h).
We also performed length distribution measurements on
the a-syn fibrils used throughout this study using quantita-
tive TEM. The length and width of ~2300 fibrils were
measured using ~50 quantitative negatively stained electron
micrographs. The length distribution (Fig. 1 i) reveals that
the fibrils (represented in the inset in Fig. 1 i) are ~23-nm
wide and ~165-nm long. If the fibrils are assimilated to
cylinders, an average fibril volume can be calculated and
the number of monomers within a fibril estimated. We used
Number of monomers per fibril ¼ Vfib=ðVaa  N

(2)
where Vfib is the volume of a cylinder ( nm long with
a y nm diameter), Vaa is the volume on average of an amino
acid (1.28  1028 m3), and N is the number of residues
within the polypeptide chain (i.e., 140).
Thus, a 165-nm-long and 23-nm-wide fibril contains
~3800 a-syn monomers. This value is twofold lower than
that derived from analytical ultracentrifugation measure-
ments. Such a discrepancy could be due to fibrils dehydra-
tion in the electron microscope and/or underestimation of
fibrils width and length because of negative staining. It
also could be due to analytical ultracentrifugation analysis
that yields accurate molecular masses for globular or
slightly elongated molecules.
The cytotoxicity of equal particle concentrations of olig-
omeric and fibrillar a-syn assemblies was assessed on
murine endothelioma H-END cells, previously shown to
be highly susceptible to the toxicity of different protein
assemblies (29) (Fig. 2 a), and human neuroblastoma SH-
SY5Y cells (Fig. 2 b) using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Whereas
oligomeric a-syn did not affect cell viability (Fig. 2, a and b,
open bars) at any concentration we tested, fibrillar a-syn ap-
peared highly toxic to the cells (Fig. 2 a and b, solid bars).
Toxicity is apparent at concentrations as low as 0.25 pM.
The toxicity we observe is not the consequence of sonica-
tion because sonicated and untreated fibrils, which lengthranges from 0.16 mm to 2 mm with an average length of
0.6 mm (see Fig. S1 a in the Supporting Material), have
similar toxicities (see Fig. S1, b and c).
We conclude from these observations that a-syn fibrils,
rather than their precursors, are toxic to the cells. As the
observed toxicity might be due to the presence of oligomeric
species in equilibrium with a-syn fibrils and/or to dissocia-
tion of the fibrils upon their dilution in the culture medium,
the fibrils were preincubated overnight in the cell culture
medium, ultrafiltered through membranes with different
molecular-mass cutoffs, and the toxicity of the filtrate as-
sessed using the MTT assay. The a-syn fibrils preincubated
in cell culture medium for >48 h retained their fibrillar
aspect (see Fig. S1 d) and toxicity. Toxicity was lost when
the fibrils were ultrafiltered through 100-KDa or 1-MDa
membranes (Fig. 2 c). These observations show that a-syn
fibrils (rather than oligomeric species that are neither in
equilibrium with the fibrils nor originating from fibrils
disassembly) are toxic to cells.Cell death and caspase-3 activation by fibrillar
a-syn
We next investigated whether the metabolic impairment we
observed using the MTT assay leads to cell death. Cells
lifted by EDTAwere incubated in the presence of increasing
concentrations of oligomeric or fibrillar a-syn, replated, and
counted after 24 h in the presence of Trypan blue to quantify
the surviving cells.
H-END and SH-SY5Y cell survival was not affected by
treatment with oligomeric a-syn at a particle concentration
ranging from 0.01 to 1 mM (Fig. 2, e and f, open bars). In
contrast, exposure of the cells to fibrillar a-syn resulted in
a dose-dependent marked decrease of surviving cells after
24 h (Fig. 2, e and f, solid bars). Indeed, 55 5 4% and
76 5 7% H-END and SH-SY5Y cells, respectively,
survived to exposure to 5 nM a-syn fibrils (Fig. 2, e and f,
respectively) as compared to ~100% survival for cells that
were exposed to oligomeric a-syn (open bars in Fig. 2, e
and f) or that were not exposed to a-syn (shaded bars in
Fig. 2, e and f).
We then measured the activation of the effector caspase-3
in H-END or SH-SY5Y cells exposed for 24 h to increasing
concentrations of fibrillar a-syn. The fibrils induced the acti-
vation of caspase-3 in a concentration-dependent manner
(Fig. 2 d). No activation of caspase-3 could be observed
when cells were exposed to oligomeric a-syn (not shown).
We conclude from these observations that apoptotic cell
death is triggered by fibrillar a-syn.Interaction of a-syn assemblies with synthetic
membranes
The interaction of a-syn assemblies with the membranes
and its consequences, e.g., perturbation of the membranes,Biophysical Journal 102(12) 2894–2905
FIGURE 2 Fibrillar a-syn is cytotoxic. (a and b)
Viability of H-END (a) and SH-SY5Y cells (b)
treated for 24 h with increasing particle concentra-
tions of on-assembly pathway oligomeric (open
bars) or fibrillar a-syn (solid bars), measured by
MTT assay. (Shaded bars) control cells treated
with assembly buffer. MTT reduction data are
mean5 SE (n ¼ 6) expressed as percentage rela-
tive to control cells treated with buffer (100%), **
P < 0.01 (Student’s t-test). (c) Viability of H-END
(shaded bars) and SH-SY5Y cells (solid bars)
treated with 0.1 nM fibrillar a-syn preincubated
in cell culture medium and ultrafiltered or not
through different cutoffs (1 MDa or 100 KDa)
before their addition to cell cultures. (d) Caspase-
3 activation in H-END (shaded bars) or SH-
SY5Y cells (solid bars) treated with increasing
particle concentrations of fibrillar a-syn. Data are
shown as fold increase relative to the caspase-3
activity measured in control cells treated with
assembly buffer. Data are mean 5 SE (n ¼ 3),
* P < 0.05 (Student’s t-test). (e and f) Percentages
of H-END (e) or SH-SY5Y (f) cell survival upon
treatment for 24 h with increasing particle concen-
trations of on-assembly pathway oligomeric (open
bars) or fibrillar a-syn (solid bars). Data are
percentages of the number of the surviving cells
in controls treated with assembly buffer (100%
survival, shaded bars). Data are mean 5 SE
(n ¼ 6), * P < 0.05; ** P < 0.01 (Student’s t-test).
2898 Pieri et al.in particular permeabilization, may account for the toxicity
we observe. Whereas soluble monomeric a-syn is known to
interact with a variety of phospholipids (30,31) and oligo-
meric species of a-syn have been shown to disrupt nega-
tively charged synthetic vesicles (32), the interaction of
on-assembly pathway oligomeric and fibrillar a-syn with
membranes and lipid vesicles of known composition has
not been yet well characterized. We therefore set up an ultra-
centrifugation floatation assay to assess, within a density
gradient, the interaction of protein assemblies with lipid
vesicles.
Both oligomeric and fibrillar a-syn (50 nM) were found
in the bottom fractions of the sucrose gradient (fractions
6–9) in the absence of lipid vesicles (see Fig. S2 a and
Fig. S3 a). In contrast, a-syn assemblies were found in the
top fractions of the gradient (fractions 1–4) when mixed
with 6.25 mM vesicles made of 1,2-dioleoyl phosphatidyl-
choline DOPC (see Fig. S2 c and Fig. S3 c), 1,2-dioleoyl
phosphatidylserine (DOPS; see Fig. S2 d and Fig. S3 d),
1,2-dioleoyl phosphatidylglycerol (DOPG; see Fig. S2 eBiophysical Journal 102(12) 2894–2905and Fig. S3 e), and lipids extracted from porcine brain (see
Fig. S2 f and Fig. S3 f). This is indicative of a-syn assem-
blies-lipid vesicle interaction. No interaction was observed
with 1-palmitoyl, 2-oleoyl phosphatidylethanolamine
(POPE) lipid vesicles (see Fig. S2 b and Fig. S3 b). The
proportion of oligomeric and fibrillar a-syn found in each
fraction of the gradient was determined. The amount of
protein in fractions 1–4, i.e., interacting with the lipid vesi-
cles, from three independent experiments was summed up
and is presented in Fig. 3, a and b. Higher amounts of a-syn
assemblies bound to DOPS and DOPG vesicles compared
to POPE and DOPC vesicles. The highest amounts of a-syn
assemblies bound to vesicles were prepared from brain lipid
extracts (see Fig. S2 f and Fig. S3 f). We then assessed the
effect of adding cholesterol (cholesterol/total lipids molar
ratio 1:4) to lipid vesicles on the interaction of a-syn assem-
blieswith themembranes. Fig. 3, a and b, Fig. S2, g and h, and
Fig. S3, g and h, show that cholesterol did not affect signifi-
cantly the interaction. Interestingly, oligomeric and fibrillar
a-syn showed similar abilities to bind lipid vesicles.
FIGURE 3 Interaction of a-syn assemblies with
synthetic membranes and their permeabilization.
(a and b) Binding of 50 nM on-assembly pathway
oligomeric (a) or fibrillar (b) a-syn to lipid unila-
mellar vesicles with different phospholipid compo-
sition (6.25 mM lipids) measured by floatation.
Membrane-bound a-syn was separated from free
a-syn by density gradient ultracentrifugation.
Data are the sum of the percentages of a-syn
detected in the top fractions 1–4 of the gradient
(see Fig. S2 and Fig. S3) in three independent
experiments (data are mean 5 SE). (c–k) Calcein
release from lipid unilamellar vesicles with
different phospholipid composition, induced by
0.2 nM oligomeric (open squares) or fibrillar a-
syn (solid squares). The a-syn assemblies were
added to calcein-loaded vesicles and the fluores-
cence measured for 30 min. The data are obtained
by subtracting the percentage of spontaneous cal-
cein release measured in control vesicles treated
with identical volumes of assembly buffer. Data
are mean5 SE (n ¼ 3).
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blies bind preferentially to negatively charged lipid vesicles
and complex lipid mixtures. We also conclude that choles-
terol does not affect binding significantly.a-Syn-mediated permeabilization of synthetic
membranes
To assess the consequences of the interaction of a-syn
assemblies with lipid vesicles, we monitored membranes’
integrity and permeability using a calcein release assay.
Unilamellar vesicles with different compositions were
prepared in the presence of calcein at a concentration
(60 mM) where fluorescence is self-quenched. 0.2 nMa-syn assemblies were then added to the vesicles and
the time course of calcein release from the vesicles
recorded.
Oligomeric a-syn induced very little permeabilization of
lipid vesicles of any composition, as judged from the negli-
gible fluorescence increase we recorded (Fig. 3, c–k, open
squares). In contrast, fibrillar a-syn (0.2 nM) permeabilized
anionic DOPS, DOPG, and soy L-a-phosphatidylinositol
(PI) vesicles (Fig. 3, c–e, solid squares). Whereas the extent
of DOPS vesicles’ permeabilization was modest (~20% cal-
cein release after 30-min incubation), it was significant and
extreme for DOPG or PI vesicles (60 and 100% calcein
release after 30-min incubation, respectively). Finally,
negligible amounts of calcein were released from vesiclesBiophysical Journal 102(12) 2894–2905
2900 Pieri et al.made of neutral phospholipids (DOPC or POPE/DOPG
molar ratio 1:1) upon incubation with fibrillar a-syn
(Fig. 3, i and j). The observation that fibrillar a-syn perme-
abilizes negatively charged, but not neutral, vesicles is
consistent with the binding data (Fig. 3, a and b, and
Fig. S3).
Interestingly, when DOPS, DOPG, or PI vesicles were en-
riched in cholesterol (cholesterol/total lipids molar ratio
1:4), the extent of permeabilization by fibrillar a-syn
strongly diminished (Fig. 3, f–h), although fibrils binding
to the vesicles did not decrease (Fig. 3, a and b and
Fig. S3). Similarly, although we found the fibrils to bind effi-
ciently to vesicles prepared from brain lipid extracts (Fig. 3,
a and b, and Fig. S3), a negligible level of fibrils-mediated
calcein release was observed for the latter vesicles upon
exposure to fibrillar a-syn (Fig. 3 k).Biophysical Journal 102(12) 2894–2905The interaction of fibrillar a-syn with the cell
membrane induces an increase in intracellular
calcium levels
Fluorescently labeled (Alexa Fluor 488; Invitrogen, Carls-
bad, CA) fibrillar a-syn binds efficiently to the plasma
membranes of cultured H-END and SH-SY5Y cells
(Fig. 4, a and b) whereas oligomeric a-syn does not (not
shown).
We investigated the consequences of the interaction of
fibrillar a-syn with the cell membranes. We monitored first
the intracellular free Ca2þ levels in real-time. To this aim,
H-END and SH-SY5Y cells loaded with Fluo-3-acetoxy-
methyl ester (Fluo-3-AM) were incubated with 5 nM Alexa
Fluor 555-labeled fibrillar a-syn, and the fluorescence
imaged over time for 20 min to monitor simultaneouslyFIGURE 4 Interaction of fibrillar a-syn with the
cell membrane induces an increase in intracellular
calcium levels. (a and b) Binding of 0.1 nM Alexa
Fluor 488-labeled a-syn fibrils to H-END (a) or
SH-SY5Y cells (b) imaged by epifluorescence
microscopy. Red fluorescence, wheat germ agglu-
tinin, tetramethylrhodamine conjugate cell mem-
brane staining. Green fluorescence, Alexa Fluor
488-labeled a-syn fibrils. Scale bars, 13 mm. (c)
Imaging of intracellular free Ca2þ alterations
and a-syn fibrils-membrane interaction at three
different incubation stages of SH-SY5Y cells
with 5 nM Alexa Fluor 555-labeled a-syn fibrils.
Cells were loaded with Fluo-3-AM. (First column)
Fluo-3 fluorescence (green). (Second column)
Alexa Fluor 555 fluorescence (red). Scale bars,
30 mm. (Third and fourth column) Higher magnifi-
cation view of merged images for the areas 1 and 2,
respectively. Scale bars, 15 mm. (d) Quantification
of the intracellular free Ca2þ increase measured
over time for all the duration of the experiment
in six representative cells. (e) Kinetics of the intra-
cellular free Ca2þ variation in the absence (green
curve) or the presence of 5 mM EGTA (solid
curve). Quantification of Alexa Fluor 555-labeled
a-syn fibrils binding to the cells (red curve). Data
are mean 5 SE of the fluorescence measured in
30 different cellular areas of 20 mm2 each.
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binding (red fluorescence).
A progressive and remarkable rise of intracellular green
fluorescence due to intracellular free Ca2þ increase was
observed upon fibrils addition (Fig. 4 c, first column). This
increase is concomitant to the accumulation of fibrillar
a-syn on the cell surface (Fig. 4 c, second column). Merged
images at higher magnification in two representative areas
(Fig. 4 c, area 1 and area 2) are shown in Fig. 4 c, third
and fourth columns, respectively.
The time courses of intracellular free Ca2þ increase in six
different randomly chosen cells are presented in Fig. 4 d. This
graph reveals cell-to-cell variability in the intracellular free
Ca2þ increase we report. Some cells exhibited rapid bursts
of intracellular free Ca2þ increase upon incubation with
fibrillar a-syn, whereas a slow and progressive increase of
intracellular freeCa2þwas observed in other cells. The extent
of free intracellular Ca2þ increase also varied significantly.
Overall, the intracellular free Ca2þ levels increased signifi-
cantly as revealed by the signals recorded from 30 different
cells, presented in Fig. 4 e (green curve). The red curve in
Fig. 4 e represents the increase in Alexa Fluor 555 fluores-
cence due to a-syn fibrils binding to the cells. Interestingly,
the rates of intracellular Ca2þ increase and fibrils binding
have similar slopes, indicating that the two events are related.
The observed alterations in intracellular free Ca2þ levels
induced by fibrillar a-syn might be due either to influx of
extracellular Ca2þ through the plasma membrane or to
Ca2þ release from the intracellular compartments where it
is stored. To identify Ca2þ origin, the culture medium was
supplemented with 5 mM EGTA and the measurements
repeated. No fibrillar a-syn-induced intracellular free
Ca2þ increase was observed under such experimental condi-
tions (Fig. 4 e, solid curve). This suggests that the free Ca2þ
influxes originate from the extracellular medium.Cytotoxicity, interaction with synthetic and
cellular membranes and consequences of the
interaction of huntingtin Exon 1 assemblies
To determine whether what we report for a-syn assemblies
is generic and illustrative of the consequences of the interac-
tion of amyloidogenic protein assemblies with cellular
membranes, we extended our study to HttEx1Q41.
Under physiological conditions, HttEx1Q41 readily
assembles into fibrils. At time 0, no fibrils were observed
by TEM (Fig. 5 a) whereas, at steady state, mature fibrils
with an average length of 136 5 3 nm and a diameter
of ~15 nm were present (Fig. 5 b).
TEM imaging and analytical ultracentrifugation measure-
ments allowed us to determine the size distribution of
HttEx1Q41 fibrils and to estimate average particle concen-
trations for the different HttEx1Q41 assemblies.
Based on the length distribution (Fig. 5 c) of soni-
cated fibrillar HttEx1Q41, we estimated the number ofHttEx1Q41 monomers within the fibrils to ~1600 (see
Eq. 2). Fibrillar HttEx1Q41 was also subjected to analyt-
ical ultracentrifugation measurements. The sedimentation
boundaries (Fig. 5 d, inset) were analyzed as for fibrillar
a-syn and yielded a broad distribution of particles centered
on a species that has a sedimentation coefficient of ~2200 S
(Fig. 5 d), consistent with particles that have a molecular
mass of ~700,000 kDa, e.g., made of ~52,000 HttEx1Q41
monomers. This value is ~30-fold larger than that derived
from length-distribution measurements. The discrepancy
between the measurements may be the consequence of
fibril-fibril association and extensive tangling (33). Because
the length-distribution analysis is based on single particles,
we considered the number derived from this measurement
more reliable than that from analytical ultracentrifugation
measurements. The number of HttEx1Q41 monomers
within the fibrils is, therefore, on average ~1600, and the
particle concentration of fibrillar HttEx1Q41 at the working
concentration 10 mM is 10 mM/~1600, i.e., ~0.006 mM. The
calculation mode we opted for overestimates the concentra-
tion of fibrillar HttEx1Q41. This number would be 10
mM/~52,000, i.e., ~0.2 nM if the average molecular mass
derived from analytical ultracentrifugation measurements
is used instead.
We next investigated the cytotoxicity of HttEx1Q41
fibrils using the MTT assay. The viability of SH-SY5Y cells
was unaffected by up to 10-mM soluble, freshly thawed
HttEx1Q41, whereas a 315 3% inhibition of MTT reduc-
tion was measured for cells exposed to 6-nM HttEx1Q41
fibrils for 24 h (Fig. 5 e). We also observed a significant
(20%) caspase-3 activation upon exposure of the cells to
6-nM fibrillar HttEx1Q41 (Fig. 5 f). Thus, although fibrillar
HttEx1Q41 concentration is overestimated by a factor 30,
fibrillar HttEx1Q41 is approximately three orders-of-magni-
tude more toxic than soluble on-assembly pathway
HttEx1Q41 oligomers.
The interaction of fibrillar HttEx1Q41 with synthetic
vesicles and cell membranes was also investigated.
HttEx1Q41 fibrils interact with both neutral DOPC and
negatively charged DOPS or DOPG synthetic lipid vesicles
(Fig. 6 a). In agreement with that, fibrillar HttEx1Q41 per-
meabilized to similar extents the different types of neutral
and anionic vesicles (Fig. 6 b). Finally, fibrillar HttEx1Q41
bound to SH-SY5Y cells (Fig. 6 c) and induced a time-
dependent increase in the intracellular free Ca2þ levels
within the cells in a manner similar to what we observed
for a-syn fibrils (Fig. 6, d and e).DISCUSSION
The pathogenesis of PD and HD is strongly associated
with the aggregation of a-syn and HttEx1 containing polyQ
tracts of 37Q and over into high molecular mass assemblies.
In vitro, a-syn and HttEx1QR 37 assemble into fibrils. The
role of the latter and the numerous oligomeric precursorsBiophysical Journal 102(12) 2894–2905
FIGURE 5 Characterization of fibrillar
HttEx1Q41 assemblies and their toxicity. (a and
b) Negatively stained TEM samples of soluble
HttEx1Q41 at time 0 of assembly (a), and of
mature HttEx1Q41 fibrils (b). Scale bars,
200 nm. (c) Length distribution of HttEx1Q41
fibrils obtained by measuring the length of ~1700
fibrils in at least 30 different quantitative nega-
tively stained electron micrographs. (d) Sedimen-
tation coefficient g*(s) distribution of HttEx1Q41
fibrils (25 mM protein monomer concentration) ob-
tained at 2000 rpm and 20C in 50 mM HEPES-
KOH pH 7.5, 150 mM NaCl and corrected to
s20,w. (Inset) Corresponding sedimentation bound-
aries, obtained at intervals of 20 min. (e) Viability
of SH-SY5Y cells treated for 24 h with 10 mM
soluble HttEx1Q41 or 6 nM HttEx1Q41 fibrils,
measured by MTT assay. Data are mean 5 SE
(n¼ 6) expressed as percentages relative to control
cells treated with buffer (** P < 0.01 Student’s
t-test). (f) Caspase-3 activation in SH-SY5Y cells
treated for 24 h with 6 nM HttEx1Q41 fibrils.
Data are expressed as fold increase compared to
the caspase activity measured in control cells
treated with identical volumes of buffer. Data are
mean5 SE (n ¼ 3), * P < 0.05 (Student’s t-test).
2902 Pieri et al.that are populated during assembly in PD and HD onset has
been actively investigated. Nonetheless, no clear consensus
has been reached so far concerning the species that is most
toxic to the cells and therefore likely to cause neurodegen-
eration. Indeed, although some reports suggest that, in
a manner similar to polyQ, fibrillar assemblies of a-syn
and HttEx1 are most toxic (11–14), others support the
view that on-assembly pathway soluble oligomeric species
are responsible for disease (17–20). The weakness of all
these reports resides in the comparison of assemblies
concentrations that differ by several orders of magnitude.
Indeed, the concentrations of insoluble fibrils and soluble
oligomeric species that are usually compared are expressed
as a function of the initial soluble protein concentration.
Such a comparison is erroneous as the concentration of an
oligomeric species is the initial concentration divided by
the number of monomers that constitute the oligomeric
species. Thus, the concentration of oligomeric assemblies
and fibrils can differ by a factor 1000 and over, because
the oligomeric assemblies are made of ~4–10 monomers
whereas fibrils are made of thousands of molecules.
The importance of assessing the respective toxicities of
the different oligomeric species has become urgent withBiophysical Journal 102(12) 2894–2905the recent findings describing spreading of fibrillar assem-
blies from one cell to another in cell cultures, animal
models, and brains of grafted patients, suggesting a critical
role for fibrillar assemblies in pathogenesis.
We document here for the first time (to our knowledge) the
respective toxicities of a-syn and pathologic HttEx1 assem-
blies at defined particle concentrations of on-assembly
pathway oligomeric species and fibrils. The molecular
mass of the oligomeric species and that of fibrils of defined
length was determined (Figs. 1 and 5, Table 1), as was the
concentration of particles in solution. Comparison of the
relative toxicity of the oligomeric species and the fibrils
shows undoubtedly that the fibrils are toxic to the cells at
picomolar concentrations whereas micromolar amounts of
oligomeric species are not (Figs. 2 and 5). The observed
fibrils-associated toxicity is neither the consequence of their
dissociation/alteration in fibrils structure nor to oligomeric
species in equilibrium with the fibrils, as the fibrils persist
upon dilution in the cell growth media (see Fig. S1 d) and
toxicity is lost upon filtration of the media through
a membrane that has a cutoff of 1 MDa (Fig. 2).
We show that fibrillar a-syn and pathologic HttEx1
trigger apoptotic cell death through the activation of
FIGURE 6 Fibrillar HttEx1Q41 binds and per-
meabilizes synthetic and cellular membranes. (a)
Binding of 0.35 nM Alexa Fluor 488-labeled
HttEx1Q41 fibrils to unilamellar vesicles with
different phospholipid composition (6.25 mM
lipids) measured by floatation. Membrane-bound
HttEx1Q41 fibrils were separated from free fibrils
by density-gradient ultracentrifugation. The distri-
bution of HttEx1Q41 fibrils in the different frac-
tions of the density gradient in the absence or the
presence of vesicles, determined by fluorescence
measurements, is shown in the graphs. (b) Calcein
release from small unilamellar DOPC (open
squares), DOPS (solid squares), or DOPG vesicles
(solid circles), induced by incubation with 1.2 nM
HttEx1Q41 fibrils for 50 min. The data represent
net values obtained by subtracting the percentage
of spontaneous calcein release measured in control
vesicles treated with buffer. Data are mean 5 SE
(n ¼ 3). (c) Binding of Alexa Fluor 488-labeled
HttEx1Q41fibrils (green) to SH-SY5Y cells
labeled with wheat germ agglutinin, tetramethylr-
hodamine conjugate (red) imaged by epifluores-
cence microscopy. Scale bar, 15 mm. (d) Imaging
of intracellular free Ca2þ alterations induced by
6 nM HttEx1Q41 fibrils in SH-SY5Y cells loaded
with Fluo-3-AM. (Upper panel) time 0. (Lower
panel) 1200 s of incubation. Scale bars, 30 mm.
(e) Quantification of the intracellular free Ca2þ
increase measured over time for all the duration
of the experiment in three representative cells.
The Cell Membrane and Fibrillar a-Syn and HttEx1 2903caspase-3 (Figs. 2 and 5). It is now established that cells
release soluble and fibrillar a-syn in their culture media.
Soluble a-syn is certainly released by exocytosis, whereas
the fibrillar form of the protein is most likely released
upon cell death after the accumulation of aggregated a-
syn within the cell. We and others have shown that released
a-syn and HttEx1 assemblies bind to neighbor cultured cells
and propagate to healthy neuronal grafts within the brain
(24–26). To better understand how the assemblies traffic
between cells, also why they are deleterious, we docu-
mented their interaction with lipid vesicles of known
composition and cells and the consequences, if any, of the
interaction. We show here using a floatation assay thatfibrillar HttEx1 displays no charge selectivity and interacts
with any kind of lipid vesicles (Fig. 6). This contrasts
with the behavior of fibrillar a-syn that exhibits, in agree-
ment with observations made on soluble a-syn (30–32),
some specificity for anionic lipid membranes (Fig. 3,
a and b, and see Fig. S2 and Fig. S3).
This may be due to the net isoelectric points and/or charge
distributions within a-syn and HttEx1 (see Fig. S4). The
interaction of fibrillar a-syn and HttEx1 with lipid vesicles
leads invariably to permeabilization of the membranes
(Fig. 3, c–k, and Fig. 6). Soluble a-syn has been reported
to bind preferentially to the cholesterol enriched lipid
rafts within the membranes (34) and cholesterol has beenBiophysical Journal 102(12) 2894–2905
2904 Pieri et al.reported to protect against membrane permeabilization
upon binding of Ab1-42 assemblies (35). We therefore as-
sessed the effect of cholesterol presence within lipid vesicles
on fibrillar a-syn and HttEx1 binding to and permeabiliza-
tion of the vesicles. We show here that although cholesterol
has a limited effect on a-syn and HttEx1 binding to the vesi-
cles (Fig. 3, a and b, and data not shown), its presence
reduces significantly a-syn and HttEx1-mediated permeabi-
lization (Fig. 3, f–h, and not shown). This is in perfect agree-
ment with an efficient binding of fibrillar a-syn and HttEx1
to lipid vesicles made of complex phospholipid mixtures
(e.g., lipid extracts from brain) where binding is accompa-
nied by limited permeabilization. In conclusion, cholesterol
appears to protect the membrane from disruption possibly
by increasing membrane stability/rigidity rather than
altering their ability to bind fibrillar a-syn and HttEx1.
Finally, we show here that the intracellular free Ca2þ
levels increase upon exposure of cells to fibrillar a-syn
and HttEx1. The changes we measured are concomitant to
fibrils binding to the cell surfaces (Figs. 4 and 6) and
are suppressed when extracellular Ca2þ is sequestered
(Fig. 4 e). This suggests that the free Ca2þ influxes originate
from the extracellular medium and that they are the conse-
quence of plasma membrane permeabilization. Oscillations
in intracellular free Ca2þ increase and variations between
individual cells were also observed (Figs. 4 and 6). This
may either reflect the time course of fibrillar a-syn and
HttEx1 binding to the cells or differences in the ability of
different cells to cope with either the fibrillar insult or ion
homeostasis regulation.
Our observations reveal similarities and differences
among fibrillar assemblies associated to neurodegenerative
disease. Overall, fibrillar assemblies rather than on-assembly
pathway oligomeric species are toxic to the cells. This
generic property of fibrils appears to be the consequence,
at least in part, of the binding of the fibrillar assemblies to
the cell membrane lipid bilayers and its permeabilization.
Studies aimed at assessing the contribution of membrane
proteins to fibrillar assemblies binding to the cell will
provide additional insights into the molecular events under-
lying fibrils-associated pathogenesis, and will allow defining
of the respective contributions of lipids and proteins in
fibrillar a-syn and HttEx binding to the cells.SUPPORTING MATERIAL
Methods, one table, four figures, and references (36,37) are available at
http://www.biophysj.org/biophysj/supplemental/S0006-3495(12)00550-4.
We thank Yannick Sourigues for technical assistance in the production of
recombinant Ex1HttQ41.
This research was supported by the Era-Net Neuron (MIPROTRAN), the
Human Frontier Science Program, the Agence Nationale de la Recherche
(ANR-08-NEUR-001-01 and ANR-09-MNPS-013-01), a ‘‘Coup d’E´lan a`
la Recherche Franc¸aise’’ award from the Bettencourt Schueller Foundation,
and the Centre National de la Recherche Scientifique.Biophysical Journal 102(12) 2894–2905REFERENCES
1. Spillantini, M. G., R. A. Crowther,., M. Goedert. 1998. a-Synuclein
in filamentous inclusions of Lewy bodies from Parkinson’s disease and
dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA. 95:6469–
6473.
2. Goedert, M. 2001. Alpha-synuclein and neurodegenerative diseases.
Nat. Rev. Neurosci. 2:492–501.
3. Lee, H. J., C. Choi, and S. J. Lee. 2002. Membrane-bound a-synuclein
has a high aggregation propensity and the ability to seed the aggrega-
tion of the cytosolic form. J. Biol. Chem. 277:671–678.
4. Uversky, V. N., and D. Eliezer. 2009. Biophysics of Parkinson’s
disease: structure and aggregation of a-synuclein. Curr. Protein Pept.
Sci. 10:483–499.
5. Schulte, J., and J. T. Littleton. 2011. The biological function of the
Huntingtin protein and its relevance to Huntington’s Disease pathology.
Curr. Trends Neurol. 5:65–78.
6. Graham, R. K., Y. Deng, ., M. R. Hayden. 2006. Cleavage at the
caspase-6 site is required for neuronal dysfunction and degeneration
due to mutant huntingtin. Cell. 125:1179–1191.
7. Sieradzan, K. A., A. O. Mechan,., D. M. Mann. 1999. Huntington’s
disease intranuclear inclusions contain truncated, ubiquitinated hun-
tingtin protein. Exp. Neurol. 156:92–99.
8. DiFiglia, M., E. Sapp,., N. Aronin. 1997. Aggregation of huntingtin
in neuronal intranuclear inclusions and dystrophic neurites in brain.
Science. 277:1990–1993.
9. Brundin, P., R. Melki, and R. Kopito. 2010. Prion-like transmission of
protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell
Biol. 11:301–307.
10. Goldberg, M. S., and P. T. Lansbury, Jr. 2000. Is there a cause-and-
effect relationship between a-synuclein fibrilization and Parkinson’s
disease? Nat. Cell Biol. 2:E115–E119.
11. Poirier, M. A., H. Li, ., C. A. Ross. 2002. Huntingtin spheroids and
protofibrils as precursors in polyglutamine fibrilization. J. Biol.
Chem. 277:41032–41037.
12. El-Agnaf, O. M., R. Jakes, ., A. Wallace. 1998. Aggregates from
mutant and wild-type a-synuclein proteins and NAC peptide induce
apoptotic cell death in human neuroblastoma cells by formation of
b-sheet and amyloid-like filaments. FEBS Lett. 440:71–75.
13. Yang, W., J. R. Dunlap, ., R. Wetzel. 2002. Aggregated polyglut-
amine peptides delivered to nuclei are toxic to mammalian cells.
Hum. Mol. Genet. 11:2905–2917.
14. Nekooki-Machida, Y., M. Kurosawa, ., M. Tanaka. 2009. Distinct
conformations of in vitro and in vivo amyloids of huntingtin-exon1
show different cytotoxicity. Proc. Natl. Acad. Sci. USA. 106:9679–
9684.
15. Novitskaya, V., O. V. Bocharova, ., I. V. Baskakov. 2006. Amyloid
fibrils of mammalian prion protein are highly toxic to cultured cells
and primary neurons. J. Biol. Chem. 281:13828–13836.
16. Caughey, B., and P. T. Lansbury, Jr. 2003. Protofibrils, pores, fibrils,
and neurodegeneration: separating the responsible protein aggregates
from the innocent bystanders. Annu. Rev. Neurosci. 26:267–298.
17. Winner, B., R. Jappelli,., R. Riek. 2011. In vivo demonstration that
a-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. USA.
108:4194–4199.
18. Arrasate, M., S. Mitra,., S. Finkbeiner. 2004. Inclusion body forma-
tion reduces levels of mutant huntingtin and the risk of neuronal death.
Nature. 431:805–810.
19. Takahashi, T., S. Kikuchi, ., O. Onodera. 2008. Soluble polyglut-
amine oligomers formed prior to inclusion body formation are
cytotoxic. Hum. Mol. Genet. 17:345–356.
20. Bucciantini, M., E. Giannoni,., M. Stefani. 2002. Inherent toxicity of
aggregates implies a common mechanism for protein misfolding
diseases. Nature. 416:507–511.
The Cell Membrane and Fibrillar a-Syn and HttEx1 290521. Danzer, K. M., D. Haasen,., M. Kostka. 2007. Different species of a-
synuclein oligomers induce calcium influx and seeding. J. Neurosci.
27:9220–9232.
22. Kagan, B. L., Y. Hirakura,., R. Azimova. 2001. The channel hypoth-
esis of Huntington’s disease. Brain Res. Bull. 56:281–284.
23. Desplats, P., H. J. Lee, ., S. J. Lee. 2009. Inclusion formation and
neuronal cell death through neuron-to-neuron transmission of a-synu-
clein. Proc. Natl. Acad. Sci. USA. 106:13010–13015.
24. Hansen, C., E. Angot, ., P. Brundin. 2011. a-Synuclein propagates
from mouse brain to grafted dopaminergic neurons and seeds aggrega-
tion in cultured human cells. J. Clin. Invest. 121:715–725.
25. Volpicelli-Daley, L. A., K. C. Luk, ., V. M. Lee. 2011. Exogenous
a-synuclein fibrils induce Lewy body pathology leading to synaptic
dysfunction and neuron death. Neuron. 72:57–71.
26. Ren, P. H., J. E. Lauckner,., R. R. Kopito. 2009. Cytoplasmic pene-
tration and persistent infection of mammalian cells by polyglutamine
aggregates. Nat. Cell Biol. 11:219–225.
27. Li, J. Y., E. Englund, ., P. Brundin. 2008. Lewy bodies in grafted
neurons in subjects with Parkinson’s disease suggest host-to-graft
disease propagation. Nat. Med. 14:501–503.
28. Ghee, M., R. Melki,., J. Mallet. 2005. PA700, the regulatory complex
of the 26S proteasome, interferes with a-synuclein assembly. FEBS J.
272:4023–4033.
29. Pieri, L., M. Bucciantini,., M. Stefani. 2009. Synthetic lipid vesicles
recruit native-like aggregates and affect the aggregation process of theprion Ure2p: insights on vesicle permeabilization and charge selec-
tivity. Biophys. J. 96:3319–3330.
30. Bartels, T., L. S. Ahlstrom,., K. Beyer. 2010. The N-terminus of the
intrinsically disordered protein a-synuclein triggers membrane binding
and helix folding. Biophys. J. 99:2116–2124.
31. Jo, E., J. McLaurin, ., P. E. Fraser. 2000. a-Synuclein membrane
interactions and lipid specificity. J. Biol. Chem. 275:34328–34334.
32. Giehm, L., D. I. Svergun, ., B. Vestergaard. 2011. Low-resolution
structure of a vesicle disrupting a-synuclein oligomer that accumulates
during fibrillation. Proc. Natl. Acad. Sci. USA. 108:3246–3251.
33. MacRaild, C. A., D. M. Hatters,., G. J. Howlett. 2003. Sedimentation
velocity analysis of flexible macromolecules: self-association and
tangling of amyloid fibrils. Biophys. J. 84:2562–2569.
34. Park, J. Y., K. S. Kim,., S. M. Park. 2009. On the mechanism of inter-
nalization of a-synuclein into microglia: roles of ganglioside GM1 and
lipid raft. J. Neurochem. 110:400–411.
35. Arispe, N., and M. Doh. 2002. Plasma membrane cholesterol controls
the cytotoxicity of Alzheimer’s disease AbP (1-40) and (1-42) peptides.
FASEB J. 16:1526–1536.
36. Schuck, P. 2000. Size-distribution analysis of macromolecules by sedi-
mentation velocity ultracentrifugation and Lamm equation modeling.
Biophys. J. 78:1606–1619.
37. Schuck, P., M. A. Perugini, ., D. Schubert. 2002. Size-distribution
analysis of proteins by analytical ultracentrifugation: strategies and
application to model systems. Biophys. J. 82:1096–1111.Biophysical Journal 102(12) 2894–2905
